Skip to content

PEEK Prostheses in the All-on-4 Concept Using Zygomatic Implants for Full-arch Rehabilitation.

Full-arch Rehabilitation of Severely Atrophic Maxillae Through the Use of Polyetheretherketone (PEEK) Prostheses Supported by Zygomatic Implants in Combination With Conventional Implants Through the All-on-4 Concept.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05589545
Acronym
PEEKPilotZyg
Enrollment
10
Registered
2022-10-21
Start date
2019-07-19
Completion date
2024-02-29
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prosthesis Survival

Keywords

prosthesis, dental implants, zygomatic implants, PEEK

Brief summary

The goal of this study is to evaluate the outcome of a Poly-ether-ether-ketone - acrylic resin prosthesis for full-arch rehabilitation of the atrophic maxillae through the All-on-4 Hybrid concept (standard and zygomatic implants) after one year of follow-up. The main question it aims to answer is: \- What is the survival outcome of the full-arch implant-supported Poly-ether-ether-ketone - acrylic resin prosthesis? The participants already rehabilitated with dental implants will receive a Poly-ether-ehter-ketone prosthesis as a definitive prosthesis.

Detailed description

Following the previous study on the full-arch rehabilitation of edentulous jaws using hybrid prostheses with polyetheretherketone (PEEK) infrastructure and acrylic resin teeth supported by implants in immediate function inserted through the All-on-4 concept it is necessary to further extend the evaluation to the full-arch rehabilitation of severily atrophic maxillae through the use of the same hybrid prostheses supported by immediate function zygomatic implants inserted alone or in combination with conventional implants. To test this, the study design to be used will be a single-centre, prospective, observational cohort study to evaluate the short term outcome of fixed prosthetic implant-supported rehabilitations. The sample of this study consists in 10 patients consecutively treated. The cohort will be evaluated after 4 to 8 weeks, 6 months, 12 months after connection of the prostheses and annually thereafter as long as the patient is willing, regarding: prosthetic survival, implant survival, marginal bone resorption, incidence of mechanical complications (loosening or fracture of prosthetic components), biological complications (peri-implant infection, suppuration, fistulae, sinus infection, gingival dehiscence), patient tissue reaction, aesthetic examination including staining, color stability and anatomic form; patient assessment of in mouth comfort, overall chewing ability, aesthetics and patient quality of life using the Oral Health Impact Profile OHIP-14 questionnaire; assessment of prosthetic preparation (technician satisfaction) concerning laboratory preparation time, clinical operative time and costs.

Interventions

A prosthetic full-arch rehabilitation of atrophic maxillae using a PEEk-acrylic resin prosthesis supported by an ensemble of standard dental implants and zygomatic dental implants, following the All-on-4 Hybrid Concept.

Sponsors

Invibio Ltd
CollaboratorINDUSTRY
Malo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective cohort study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects who, in the opinion of the Investigator, are able to understand this clinical study, co-operate with the procedures and are willing to return to the clinic for all the required post-operative follow-ups. * Subjects who are able to give voluntary, written informed consent to participate in this clinical study and from whom consent has been obtained.

Exclusion criteria

* Female Subjects who are pregnant. * Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-ups or treatment outcomes. * Subjects with any condition that would compromise their participation and follow-up in this clinical study. * Subjects who are currently enrolled in a clinical study.

Design outcomes

Primary

MeasureTime frameDescription
Survival of the prosthesisone yearEvaluation of the survival for the PEEK-acrylic resin implant-supported prosthesis; nominal (survival,failure)

Secondary

MeasureTime frameDescription
Incidence of biological complicationsone yearPeri-implant infection, abscess, fistulae, suppuration, sinus infection, gingival dehiscence; Nominal (no incidence, incidence)
Incidence of mechanical complicationsone yearLoosening or fracture of prosthetic components; Nominal (no incidence, incidence)
Marginal bone resorption (standard implants)one yearMeasured through periapical radiographs, in mm between the implant shoulder and the most apical portion of implant-bone contact; Scale
Patient tissue reactionone yearVisual analogue scale (0-10 cm); 0:very poor; 10: very good
Denture stainingone yearVeneer staining; 0:heavily stained; 10: no stains
Color stabilityone yearColor stability; 0: heavy discoloration; 10: no discoloration
Survival of the implantsone yearEvaluation of the survival for implants supporting the PEEK-acrylic resin implant-supported prosthesis; nominal (survival,failure)
ln mouth comfortone yearVisual analogue scale (0-10 cm); 0:very poor; 10: very good
Aestheticsone yearVisual analogue scale (0-10 cm); 0:very poor; 10: very good
Overall Chewing abilityone yearVisual analogue scale (0-10 cm); 0:very poor; 10: very good
Oral Health Impact ProfileOne yearOral Health Impact Profile OHIP-14 questionnaire
Laboratory preparation timeone yearAverage laboratory time to produce the finished prosthesis, the active technician time spent in CAD design, Cam mill and veneering.
Clinical operative timeone yearAverage operative time to load the final prosthesis
Anatomic formone yearAnatomic form; 0: Complete loss of anatomic form; 10: maintained anatomic form

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026